Bicycle Therapeutics plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$2.30 | -$0.41 | -$1.25 |
| Q2 2024 | 2 | -$2.04 | -$0.37 | -$1.11 |
| Q3 2024 | 2 | -$1.47 | -$0.26 | -$0.80 |
| Q4 2024 | 7 | -$1.04 | -$0.60 | -$0.85 |
| Q1 2025 | 3 | -$1.62 | -$0.29 | -$0.88 |
| Q2 2025 | 2 | -$1.64 | -$0.29 | -$0.89 |
| Q3 2025 | 2 | -$1.75 | -$0.31 | -$0.95 |
| Q4 2025 | 2 | -$1.71 | -$0.31 | -$0.93 |
Bicycle Therapeutics plc Earnings Date And Information
Bicycle Therapeutics plc last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.74 earnings per share for the quarter, topping analysts' consensus estimates of $-0.78 by $0.04. The company had revenue of 2.68 M for the quarter and had revenue of 26.98 M for the year. Bicycle Therapeutics plc has generated $-5 earnings per share over the last year ($-5.08 diluted earnings per share) and currently has a price-to-earnings ratio of -8.49. Bicycle Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Bicycle Therapeutics plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | -$0.78 | -$0.74 | 0.04 | $6.82 M | $2.68 M |
| 08/06/2024 | Q2 2024 | -$1.10 | -$0.77 | 0.33 | $6.13 M | $9.37 M |
| 05/02/2024 | Q1 2024 | -$1.26 | -$0.62 | 0.64 | $19.52 M | |
| 02/20/2024 | Q4 2023 | -$1.23 | -$1.16 | 0.07 | $5.33 M | |
| 11/02/2023 | Q3 2023 | -$1.06 | -$1.26 | -0.2 | $12.94 M | $5.35 M |
| 08/03/2023 | Q2 2023 | -$1.10 | -$1.41 | -0.31 | $5.78 M | $11.40 M |
| 05/04/2023 | Q1 2023 | -$1.06 | -$1.30 | -0.24 | $4.90 M | |
| 02/28/2023 | Q4 2022 | -$1.06 | -$1.01 | 0.05 | $3.19 M | |
| 11/03/2022 | Q3 2022 | -$0.98 | -$0.96 | 0.02 | $5.70 M | $3.04 M |
| 08/04/2022 | Q2 2022 | -$0.82 | -$0.90 | -0.08 | $3.69 M | $4.38 M |
| 05/05/2022 | Q1 2022 | -$0.70 | -$0.93 | -0.23 | $3.86 M | |
| 03/01/2022 | Q4 2021 | -$0.60 | -$0.63 | -0.03 | $3.77 M | |
| 11/04/2021 | Q3 2021 | -$0.67 | -$0.59 | 0.08 | $5.75 M | $4.33 M |
| 08/05/2021 | Q2 2021 | -$0.72 | -$0.74 | -0.02 | $2.31 M | $1.79 M |
| 05/06/2021 | Q1 2021 | -$0.66 | -$0.73 | -0.07 | $1.81 M | |
| 03/11/2021 | Q4 2020 | -$0.50 | -$0.83 | -0.33 | $3.85 M | |
| 11/05/2020 | Q3 2020 | -$0.66 | -$0.52 | 0.14 | $2.73 M | $3.84 M |
| 08/05/2020 | Q2 2020 | -$0.55 | -$0.67 | -0.12 | $2.36 M | $1.57 M |
| 05/07/2020 | Q1 2020 | $0.11 | -$0.63 | -0.74 | $1.13 M | |
| 03/10/2020 | Q4 2019 | -$0.52 | -$0.25 | 0.27 | $5.28 M |
Bicycle Therapeutics plc Earnings: Frequently Asked Questions
-
When is Bicycle Therapeutics plc's earnings date?
Bicycle Therapeutics plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
Did Bicycle Therapeutics plc beat their earnings estimates last quarter?
In the previous quarter, Bicycle Therapeutics plc (:BCYC) reported $-0.74 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.78 by $0.04.
-
How can I listen to Bicycle Therapeutics plc's earnings conference call?
The conference call for Bicycle Therapeutics plc's latest earnings report can be listened to online.
-
How can I read Bicycle Therapeutics plc's conference call transcript?
The conference call transcript for Bicycle Therapeutics plc's latest earnings report can be read online.
-
How much revenue does Bicycle Therapeutics plc generate each year?
Bicycle Therapeutics plc (:BCYC) has a recorded annual revenue of $26.98 M.
-
How much profit does Bicycle Therapeutics plc generate each year?
Bicycle Therapeutics plc (:BCYC) has a recorded net income of $26.98 M. Bicycle Therapeutics plc has generated $-5.08 earnings per share over the last four quarters.
-
What is Bicycle Therapeutics plc's price-to-earnings ratio?
Bicycle Therapeutics plc (:BCYC) has a price-to-earnings ratio of -8.49 and price/earnings-to-growth ratio is -0.26.
